期刊文献+

田口设计筛选硝苯地平喷雾干燥分散体的处方研究 被引量:4

Formulation Study for Nifedipine Spray Dried Dispersion with Taguchi Design
原文传递
导出
摘要 目的考察喷液处方对硝苯地平喷雾干燥分散体(spray dried dispersion,SDD)的表征和非漏槽条件下溶出度的影响。方法采用minitab DOE(design of experiment)中的田口设计(Taguchi design)方法,以120 min以内的溶出度曲线下面积(AUC_(0~120 min))及120 min时的溶出浓度和最大浓度的比值(C_(120)/C_(max))为评价指标,考察载体材料的种类和用量及喷雾溶液的固含量对硝苯地平SDD的药物存在状态和体外溶出度的影响。结果硝苯地平与聚合物的比例对固体分散体中药物的存在状态和体外溶出度均有显著影响,固含量对结果影响较小。以共聚维酮为载体材料时,可以获得比醋酸羟丙甲基纤维素琥珀酸酯(HPMCAS)更高的最大溶出浓度(C_(max)),但是HPMCAS的抑制药物重结晶的效果明显优于共聚维酮,其中药物-HPMCAS LG 1∶4时可以获得最大的C_(max)和AUC_(0~120 min)。结论硝苯地平与HPMCAS LG按照1∶4的比例配成固含量10%的溶液进行喷雾干燥,可以制得溶出度显著改善的SDD。 OBJECTIVE To determine the effect of solution formulation on characteristics and non-sink dissolution of nifedipine spray dried dispersion(SDD). METHODS Taguchi method in minitab software was used for experiment design. The area under dissolution curve within 120 min(AUC(0-120 min)) and the ratio of released drug at 120 min to the maximum released drug(C(120)/C(max)) were applied as evaluation index to investigated the effect of polymers type, dosage and solid content of feed solution on drug state in nifedipine SDD and in-vitro dissolution. RESULTS Ratio of nifedipine to polymer had dramatic effect on drug state in SDD and in-vitro dissolution while solid content in feed solution affects a little. Copovidone based SDD got higher C(max) compared with Hydroxypropyl methylcellulose acetate succinate(HPMCAS), but HPMCAS performed better in inhibiting recrystalization during dissolution test and storage. SDD with nifedipine-HPMCAS LG 1∶4 could get highest C(max) and AUC(0-120 min). CONCLUTION Spray drying solution with nifedipine-HPMCAS LG 1∶4 with solid content of 10% can get great SDD with optimized dissolution.
作者 张礼仲 王如意 刘怡 ZHANG Lizhong;WANG Ruyi;LIU yi(Jiangzhong Pharmaceutical Co.,Ltd.,Nanchang 330006,China;Ashland China Holding Co.,Ltd.,Shanghai 200233,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2018年第9期1303-1307,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 硝苯地平 喷雾干燥 固体分散体 溶出度 nifedipine spray dry solid dispersion dissolution
  • 相关文献

参考文献1

二级参考文献19

  • 1赵巧玲,高永良.固体分散体的释药机制及其稳定性的研究进展[J].国外医学(药学分册),2005,32(1):52-56. 被引量:19
  • 2李力,周全,张恒弼.固体分散体的研究进展[J].药学情报通讯,1994,12(3):188-190. 被引量:5
  • 3Six K, Berghmans H, Leuner C, et al. Characterization ofsolid dispersions of itraconazole and hydroxypropylmethyl-cellulose prepared by melt extrusion,Part II [ J ]. PharmRes,2003,20(7) : 1047-1054. 被引量:1
  • 4Forster A, Hempenstall J, Rades T. Characterization ofglass solutions of poorly water-soluble drugs produced bymelt extrusion with hydrophilic amorphous polymers[ J].J Pharm Pharmacol,2001 ’53(3) :303-315. 被引量:1
  • 5Wang Liang,Cui Fude,Hayase T,et al. Preparation and e-valuation of solid dispersion for nitrendipine-carbopol andnitrendipine-HPMCP systems using a twin screw extruder[J]. Chem Pharm Bull ( Tokyo),2005 ,53 ( 10): 1240-1245. 被引量:1
  • 6Hiilsmann S,Backensfeld T,Keitel S,et al. Melt extrusion-an alternative method for enhancing the dissolution rate of17 beta-estradiol hemihydrate [ J ]. Eur Pharm Biopharm,2000,49(3) :237-242. 被引量:1
  • 7Van den Mooter G,Wuyts M,Blaton N,et al. Physical sta-bilisation of amorphous ketoconazole in solid dispersionswith polyvinylpyrrolidone K25 [ J ]. Eur J Pharm Sci,2001,12(3) :261-269. 被引量:1
  • 8Weuts I, Kempen D, Six K, et al. Evaluation of differentcalorimetric methods to determine the glasstransition tem-perature and molecular mobility below T ( g) for amor-phous drugs[ J]. Int J Pharm,2003 ,259( 1/2) :17-25. 被引量:1
  • 9魏敏,关皎,徐璐,姚慧敏,李三鸣.熔融法制备布洛芬固体分散体[J].沈阳药科大学学报,2010,27(1):15-19. 被引量:13
  • 10梁志凌,马江耀.固体分散体在兽药制剂开发中的应用[J].广东畜牧兽医科技,2010,35(2):11-13. 被引量:2

共引文献10

同被引文献51

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部